ANK2 V2369A - GET-Evidence

Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.

To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.

Please help improve GET-Evidence by evaluating evidence for this variant!


(See the latest version)

ANK2 V2369A

(ANK2 Val2369Ala)

You are viewing an old version of this page that was saved on December 27, 2009 at 3:53pm by Genome Importing Robot.

Added in this revision:

Short summary


Variant evidence
Computational -
Functional -
Case/Control -
Familial -
Clinical importance
Severity -
Treatability -
Penetrance -


Insufficiently evaluated not reviewed

(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)

Inheritance pattern


Summary of published research, and additional commentary


Allele frequency

  • C @ chr4:114276880: 14.3% (1539/10758) in EVS
  • C @ chr4:114496328: 11.7% (15/128) in GET-Evidence
  • Frequency shown in summary reports: 14.3% (1539/10758)



Other external references

  • Score: 0.001 (benign)
    Web search results (2 hits -- see all)
  • AceView: Gene:ANK2, a comprehensive annotation of human ...
    AceView offers a comprehensive annotation of human, mouse and nematode genes reconstructed by co-alignment and clustering of all publicly available mRNAs and ESTs on ...
  • ANK2_Ankyrin mutations
    found in 6subjects spanning from normal to over LQT phenotype and cardiac arrest. ... V2369A. cSNP. TdP. Mank-Seymour 2006. A2423P. cSNP. TdP. Mank-Seymour 2006. P2835S. cSNP. TdP. Mank ...

Other in silico analyses

  • NBLOSUM100 score = 2
  • GET-Evidence autoscore = 2

Edit history

Gene search

"GENE" or "GENE A123C":

Log in